ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Osteoarthritis"

  • Abstract Number: 2656 • ACR Convergence 2024

    Short-Term Effectiveness of a Walk with Ease Program Delivered by Telephone on Arthritis-Related Symptoms, Function, and Physical Activity

    Christine Pellegrini, Sara Wilcox, Yesil Kim, Katherine Devivo, Scott Jamieson, Kailyn Horn and Daniel Heidtke, University of South Carolina, Columbia, SC

    Background/Purpose: Walk With Ease (WWE) is a 6-week arthritis-appropriate evidence-based physical activity program traditionally offered in a face-to-face format. However, as many populations encounter participation…
  • Abstract Number: 0175 • ACR Convergence 2024

    Do Knee Strength and Pain Relate to Developing Stair Climbing Difficulty for Knee Osteoarthritis?

    Jason Jakiela1, Yvonne Golightly2, Sydney Liles3, Judy Foxworth4 and Daniel White5, 1Winston-Salem State University, Winston-Salem, NC, 2University of Nebraska Medical Center, Omaha, NE, 3University of Delaware, Elkton, MD, 4Winston-Salem State University, Elon, NC, 5University of Delaware, Newark, DE

    Background/Purpose: Knee osteoarthritis (OA) is a leading cause of functional limitation in older adults, and stair climbing difficulty is often the first-reported limitation. Previous work…
  • Abstract Number: 0981 • ACR Convergence 2024

    The Causal Effect of Sex Hormone-related Drugs on the Risk of Osteoarthritis – A Mendelian Randomization Study

    Xing Xing1, Ziyuan Shen2, Jianan Zhu3, Yining Wang2, Xingzhong Jin4 and Guoqi Cai2, 1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Baltimore, MD, 2Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China (People's Republic), 3Department of Biostatistics, School of Public Health, New York University, New York, NY, 4Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia

    Background/Purpose: Osteoarthritis (OA) is a prevalent joint disorder characterized by joint pain, disability, and the loss of articular cartilage, imposing a significant burden on patients…
  • Abstract Number: 1189 • ACR Convergence 2024

    Certain Dosages of Fasinumab Provides Superior Benefits over Placebo in Mitigating Osteoarthritis Symptoms Albeit at Increased Health Detriments: A Systematic Review and Meta-Analysis

    Muhammad Sohaib Khan1, Wania Moeen2, Umm E Salma Shabbar Banatwala2, Muhammad Usman2, Umar Mahmood2, Syed Ashad Ahmed Fatmi2, Syed Muhammad Muneeb Akhtar2, Hania Shahzad3, Muhammad Talal Ibrahim4, Nisar Ahmed5, Badaruddin Sahito2 and Muhammad Sohaib Asghar6, 1Dow University of Health Sciences, Karachi, Pakistan, 2Dow University of Health Sciences, Karachi, Sindh, Pakistan, 3UC Davis Health, Sacramento, CA, 4The Ohio State University Wexner Medical Center, Columbus, OH, 5Rapido’s Clinica Familiar, Chicago, 6AdventHealth, Sebring, FL

    Background/Purpose: Fasinumab, a newly developed anti-nerve growth factor monoclonal antibody, is currently under investigation for its potential to alleviate symptoms in osteoarthritis patients. This meta-analysis…
  • Abstract Number: 1205 • ACR Convergence 2024

    OARSI Initiative to Develop Classification Criteria for Early-Stage Symptomatic Knee OA (EsSKOA): What Should Be Considered in the Differential Diagnosis of EsSKOA?

    Gillian Hawker1, Lauren King1, Jean Liew2, Quike Wang3, Armaghan Mahmoudian4, Nuria Jansen5, Ian Stanaitis6, Jos Runhaar5, Tom Appleton7, Aleksandra Turkiewicz8, Martin Englund9, Stefan Lohmander9, Ida Kristin Haugen10 and Tuhina Neogi11, and OARSI Early-stage Symptomatic Knee Osteoarthritis Initiative, 1University of Toronto, Toronto, ON, Canada, 2Boston University, Boston, MA, 3Shanghai Sixth People's Hospital, Shanghai, China (People's Republic), 4University of West Florida, Pensacola, FL, 5Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 6Women's College Hospital, Toronto, ON, Canada, 7The University of Western Ontario, London, ON, Canada, 8,Lund University, Lund, Sweden, 9Lund University, Lund, Sweden, 10Diakonhjemmet Hospital, Oslo, Norway, 11Boston University Chobanian & Avedisian School of Medicine, Boston, MA

    Background/Purpose: Osteoarthritis Research Society International (OARSI) has launched an initiative to develop classification criteria for early-stage symptomatic knee osteoarthritis (EsSKOA). In individuals with undiagnosed knee…
  • Abstract Number: 1655 • ACR Convergence 2024

    Peroxisome Proliferator-Activated Receptor α Is a Disease-Modifying Target for Osteoarthritis

    UXIA NOGUEIRA-RECALDE1, christian García-Dominguez2, Patricia Diaz-Rodriguez3, francisco J Blanco4, eduardo Dominguez3 and BEATRIZ CARAMES1, 1INSTITUTO DE INVESTIGACION BIOMEDICA DE A CORUÑA (INIBIC), A Coruña, Spain, 2IINSTITUTO DE INVESTIGACION BIOMEDICA DE A CORUÑA (INIBIC), A Coruña, Spain, 3UNIVERSIDAD DE SANTIAGO DE COMPOSTELA, SANTIAGO DE COMPOSTELA, Spain, 4INIBIC-University of A Coruña, A Coruña, Spain

    Background/Purpose: Disease-modifying drugs (DMOADs) to prevent Osteoarthritis (OA) are an urgent clinical need. Recent advances demonstrated that targeting senescence and autophagy in chondrocytes might be…
  • Abstract Number: 2003 • ACR Convergence 2024

    Cumulative Incidence of Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis in Lung Cancer Patients with and Without Hip Osteoarthritis and Impacts on Survival

    Laura Cappelli1, Shadpour Demehri1, Joseph Murray1, Julie Brahmer1, Elena Ghotbi1, Durrant Barasa1, Clifton Bingham2 and Ami Shah3, 1Johns Hopkins School of Medicine, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Division of Rheumatology, Johns Hopkins University, Ellicott City, MD

    Background/Purpose: Rheumatologists are increasingly called upon to manage patients with inflammatory arthritis (IA) due to immune checkpoint inhibitor (ICI) therapy. The pathogenesis of ICI-IA is…
  • Abstract Number: 2101 • ACR Convergence 2024

    Patient Characteristics Associated with Objectively-Assessed Physical Activity in Veterans with Knee Osteoarthritis

    Hannah Brubeck1, David Azizi2, Sarah Wetzel2, Marianna Olave2, Rachel Gillcrist3, Bridget Kramer4, Bibiana Ateh5, Daniel White6, Carla Scanzello7, Tuhina Neogi8, Alexis Ogdie9, Bryant England4, Mercedes Quinones10, Katherine Wysham11 and Joshua Baker7, 1VA Puget Sound Health Care System, Seattle, WA, 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 3Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 4University of Nebraska Medical Center, Omaha, NE, 5Washington DC VA Medical Center, Washington, DC, 6University of Delaware, Newark, DE, 7University of Pennsylvania, Philadelphia, PA, 8Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 9Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 10Washington DC VA Medical Center, Bethesda, MD, 11VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

    Background/Purpose: Despite strong recommendations for physical activity in knee osteoarthritis (KOA) clinical practice guidelines, only a small fraction of those with KOA meet guidelines for…
  • Abstract Number: PP10 • ACR Convergence 2024

    Walking Away from Arthritis Pain: Exercise Helped Me Manage Sarcoidosis and Osteoarthritis Physically and Emotionally

    Bridget Kelly, Hospital for Special Surgery, Rockville Centre, NY

    Background/Purpose: In 2004, we moved to a new home with 2 small children, when I started experiencing terrible joint pain. For 2 years I was…
  • Abstract Number: 0364 • ACR Convergence 2024

    Exploring 24-Hour Temporal Trends in Symptoms and Treatment of Rheumatic Disease Through Google Search Trends

    Insa Mannstadt1, J. Alex B. Gibbons2 and Bella Mehta3, 1Columbia University VP&S, New York, NY, 2Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: Symptoms of rheumatic diseases such as joint stiffness and pain are known to peak in the early morning hours. In the digital age, tracking…
  • Abstract Number: 1003 • ACR Convergence 2024

    Association Between Metabolic Markers and Knee Osteoarthritis: A Cross-sectional Study Using the Korea National Health and Nutrition Examination Survey 2009 to 2013

    Junyong Park, Minkook Son, Sang Yeob Lee, Won Tae Chung and Sung Won Lee, Dong-A University College of Medicine, Busan, Republic of Korea

    Background/Purpose: Low-grade, prolonged inflammation of involved joint is characteristic of osteoarthritis (OA) pathogenesis. Thus susceptibility to inflammation has been considered as a risk factor for…
  • Abstract Number: 1190 • ACR Convergence 2024

    Cross-sectional Associations Among Sonographic and Radiographic Features and Symptoms Scores in a Population-Based Cohort

    Katherine Yates1, Carolina Alvarez2, Sahar Sawani3, Liubov Arbeeva4, Todd Schwartz5, Serena Savage-Guin6, Jordan Renner7, Catherine Bakewell8, Minna Kohler9, Janice Lin10, Jonathan Samuels11 and Amanda Nelson3, 1University of North Carolina Medical Center, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Miami, FL, 3University of North Carolina at Chapel Hill, Chapel Hill, NC, 4University of North Carolina, Chapel Hill, Carrboro, NC, 5University of North Carolina-Chapel Hill, Chapel Hill, NC, 6Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill,, Chapel Hill, NC, 7Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 8Intermountain Healthcare, Salt Lake City, UT, 9Massachusetts General Hospital, Boston, MA, 10Stanford University, Palo Alto, CA, 11NYU Langone, Rye Brook, NY

    Background/Purpose: Ultrasound (US) allows for visualization of features of knee osteoarthritis (KOA) including osteophytes, meniscal extrusion, synovitis, and cartilage damage. The current analysis aimed to…
  • Abstract Number: 1206 • ACR Convergence 2024

    Association of Effusion-synovitis on Knee Pain in Early and Later-stage Knee Osteoarthritis

    Lindsey MacFarlane1, Mike Paskewicz2, Jamie Collins2 and Jeffrey Katz2, 1Brigham and Women's Hospital, Hanover, NH, 2Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Pain in knee osteoarthritis (OA) is associated with structural features including effusion-synovitis (E-S) and radiographic severity. Prior studies show a cross-sectional association between larger…
  • Abstract Number: 1656 • ACR Convergence 2024

    Loss of Nr4a1 Expression Protects Cartilage During Post-traumatic Osteoarthritis

    Katherine Escalera-Rivera, Jennifer Jonason and Jennifer Anolik, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Osteoarthritis (OA) is a complex disease involving pathological processes in joint tissues such as the cartilage and synovium. Cartilage is degraded by matrix metalloproteinases…
  • Abstract Number: 2061 • ACR Convergence 2024

    Associations Between Intramyocellular Lipid and Muscle Function in Patients with Osteoarthritis

    Rachel Gillcrist1, Marianna Olave2, Ryan Armbruster3 and Joshua Baker4, 1Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 2Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, 3University of Pennsylvania, Philadelphia, 4Department of Medicine, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Intramyocellular lipids (IMCL), stored within lipid droplets in skeletal muscle cells, serve as an important metabolic fuel source during exercise. Endurance athletes have demonstrated higher…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 63
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology